Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000697295 | SCV000825895 | pathogenic | Progressive myoclonic epilepsy | 2018-05-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln22*) in the CSTB gene. It is expected to result in an absent or disrupted protein product. While this variant is not present in population databases, the frequency information is unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals with CSTB-related disease. Loss-of-function variants in CSTB are known to be pathogenic (PMID: 8596935). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001784328 | SCV002023428 | likely pathogenic | Unverricht-Lundborg syndrome | 2022-11-01 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV001784328 | SCV004171848 | likely pathogenic | Unverricht-Lundborg syndrome | criteria provided, single submitter | clinical testing |